Evidence map›Paper›PMID 28386604›Full record

ArticleScience immunology2017

Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.

A A R Thompson, R S Dickinson, F Murphy, J P Thomson, H M Marriott, A Tavares, J Willson, L Williams, A Lewis, A Mirchandani and 25 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. The Role of Hypoxia in Longevity.Aging and disease · 2025
    Review
  6. Review
  7. Article
  8. A hypoxic young lady in an acute confusional state.Breathe (Sheffield, England) · 2024
    Article
  9. Article
  10. βFrontiers in immunology · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 5 institutions in 3 countries.

A A R ThompsonDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
R S DickinsonMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
F MurphyMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
J P ThomsonMRC Human Genetics Unit at the Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
H M MarriottDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
A TavaresUniversity of Edinburgh/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
J WillsonMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
L WilliamsDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
A LewisDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
A MirchandaniMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
P Dos Santos CoelhoMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
C DohertyMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
E RyanMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
E WattsMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
N M MortonUniversity of Edinburgh/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
S ForbesUniversity of Edinburgh/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
R H StimsonUniversity of Edinburgh/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
A G HameedDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
N ArnoldDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
J A PrestonDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
A LawrieDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
V FinisguerraLaboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, VIB, Leuven, B3000, Belgium; Laboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, Department of Oncology, KU Leuven, Leuven, B3000, Belgium.
M MazzoneLaboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, VIB, Leuven, B3000, Belgium; Laboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, Department of Oncology, KU Leuven, Leuven, B3000, Belgium.
P SadikuMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
J GoveiaLaboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Centre, VIB, Leuven, B3000, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Centre, K.U. Leuven, B3000, Belgium.
F TavernaLaboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Centre, VIB, Leuven, B3000, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Centre, K.U. Leuven, B3000, Belgium.
P CarmelietLaboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Centre, VIB, Leuven, B3000, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Centre, K.U. Leuven, B3000, Belgium.
S J FosterDepartment of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK.
E R ChilversDepartment of Medicine, University of Cambridge, Cambridge, UK.
A S CowburnDepartment of Medicine, University of Cambridge, Cambridge, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, UK.
D H DockrellDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
R S JohnsonDepartment of Physiology, Development and Neuroscience, University of Cambridge, UK.
R R MeehanMRC Human Genetics Unit at the Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.
M K B WhyteMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
S R WalmsleyMRC/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
University of Sheffield · GBUniversity of Cambridge · GBBridge University · SSKU Leuven · BEVIB-KU Leuven Center for Cancer Biology · BE

Funding

British Heart Foundation FS/13/48/30453Medical Research Council G0802255Medical Research Council MC_PC_U127574433Medical Research Council MR/K023845/1Wellcome Trust 076945Wellcome Trust 098516Wellcome Trust 100981Wellcome Trust 110086Wellcome Trust 110086/Z/15/Z
6 · The paper itself

Abstract

Hypoxia and bacterial infection frequently co-exist, in both acute and chronic clinical settings, and typically result in adverse clinical outcomes. To ameliorate this morbidity, we investigated the interaction between hypoxia and the host response. In the context of acute hypoxia, both

Identifiers

PMID28386604
PMCPMC5380213
OpenAlexW2587295516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.